MD Financial Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-50
Closed -$4K – 305
2021
Q3
$4K Buy
+50
New +$4.2K ﹤0.01% 295

Other funds holding ARKG

MD Financial Management's ARKG Position: Q4 2021 in Review

MD Financial Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 50 shares — an estimated $4K sold.

MD Financial Management first reported a position in ARKG in Q3 2021 and held it in 1 quarter. The position peaked at $4K in Q3 2021. 462 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

  • MD Financial Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
  • MD Financial Management sold 50 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $4K.
  • MD Financial Management first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 1 quarter.
  • MD Financial Management's ARK Genomic Revolution ETF position peaked at $4K in Q3 2021.
  • 462 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on MD Financial Management's 13F filing for Q4 2021, filed 14 Feb 2022.